Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Nagel

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Infectious Disorders Drug Targets|February 20, 2010
Virus vasculopathy and stroke: an under-recognized cause and treatment targetM A Nagel, R Mahalingam, R J Cohrs, et al.
Neuropathology and Applied Neurobiology|February 24, 2011
Review: The neurobiology of varicella zoster virus infectionD Gilden, R Mahalingam, M A Nagel, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 26, 2000
Vigilin binding selectively inhibits cleavage of the vitellogenin mRNA 3'-untranslated region by the mRNA endonuclease polysomal ribonuclease 1K S Cunningham, R E Dodson, M A Nagel, et al.
Virology|February 27, 2001
Paramyxovirus fusion (F) protein: a conformational change on cleavage activationR E Dutch, R N Hagglund, M A Nagel, et al.
Clinical Neurology and Neurosurgery|January 1, 1989
Spontaneous spinal epidural hematoma in a 7-year-old girl. Diagnostic value of magnetic resonance imagingM A Nagel, I P Taff, E L Cantos, et al.
Neurology|February 9, 2007
The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathyM A Nagel, B Forghani, R Mahalingam, et al.
Neurology|July 15, 2011
Varicella zoster virus vasculopathy: analysis of virus-infected arteriesM A Nagel, I Traktinskiy, Y Azarkh, et al.
Neurology|March 12, 2008
The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic featuresM A Nagel, R J Cohrs, R Mahalingam, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Infectious Disorders Drug Targets|February 20, 2010
Virus vasculopathy and stroke: an under-recognized cause and treatment targetM A Nagel, R Mahalingam, R J Cohrs, et al.
Neuropathology and Applied Neurobiology|February 24, 2011
Review: The neurobiology of varicella zoster virus infectionD Gilden, R Mahalingam, M A Nagel, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 26, 2000
Vigilin binding selectively inhibits cleavage of the vitellogenin mRNA 3'-untranslated region by the mRNA endonuclease polysomal ribonuclease 1K S Cunningham, R E Dodson, M A Nagel, et al.
Virology|February 27, 2001
Paramyxovirus fusion (F) protein: a conformational change on cleavage activationR E Dutch, R N Hagglund, M A Nagel, et al.
Clinical Neurology and Neurosurgery|January 1, 1989
Spontaneous spinal epidural hematoma in a 7-year-old girl. Diagnostic value of magnetic resonance imagingM A Nagel, I P Taff, E L Cantos, et al.
Neurology|February 9, 2007
The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathyM A Nagel, B Forghani, R Mahalingam, et al.
Neurology|July 15, 2011
Varicella zoster virus vasculopathy: analysis of virus-infected arteriesM A Nagel, I Traktinskiy, Y Azarkh, et al.
Neurology|March 12, 2008
The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic featuresM A Nagel, R J Cohrs, R Mahalingam, et al.
Pageof 1